Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Rating of “Buy” from Analysts
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has received an average rating of “Buy” from the fourteen brokerages that are presently covering the stock, Marketbeat.com reports. Fourteen equities research analysts have rated the stock with a buy rating. The average 12 month target price among analysts that have covered the stock in the last […]
8 Nov 10:36 · The Markets Daily